Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Prevymis (letermovir)
pCPA File Number:
21052
Negotiation Status:
Concluded with an LOI
Indication(s):
Cytomegalovirus infection prophylaxis
Sponsor/Manufacturer:
Merck Canada Inc.
CADTH Project Number:
SR0545-000
pCPA Engagement Letter Issued:
2018-11-29
Negotiation Process Concluded:
2019-12-18